ARTICLE | Clinical News

Cortiment MMX budesonide regulatory update

November 3, 2014 8:00 AM UTC

Cosmo and Ferring said Cortiment MMX budesonide received approval in 27 EU countries under the Mutual Recognition Procedure to treat mild to moderate active ulcerative colitis (UC). Ferring launched the product in the Netherlands in November 2013 and plans to launch it in the additional 27 countries in the "coming months." Cortiment MMX is budesonide delivered using Cosmo's MMX multi-matrix system technology. ...